CRW

CRANEWARE PLC ORD 1P

Stock London Stock Exchange – Stock Market Prices, News & Analysis

Craneware PLC develops and provides financial analytics and revenue management software solutions for hospitals and healthcare systems.

£ 14.65
1.34 %

CRANEWARE PLC ORD 1P

£ 14.65
1.34 %
CRW

Craneware PLC develops and provides financial analytics and revenue management software solutions for hospitals and healthcare systems.

Price history of CRANEWARE PLC ORD 1P
Price history of CRANEWARE PLC ORD 1P

Performance & Momentum

6 Months 33.68 %
1 Year 5.44 %
3 Years 33.28 %
5 Years 38.89 %

Strategic Analysis

CRANEWARE PLC ORD 1P • 2026

Craneware PLC positions itself as a specialist in financial analytics and revenue management software solutions dedicated to hospitals and healthcare systems. Its differentiation is based on deep sector expertise combined with a targeted technology offering, addressing the complex financial management needs of the healthcare sector.

Strengths
  • Niche positioning in a growing segment linked to healthcare and financial technology
  • Recognized expertise in hospital financial data analytics
  • Technology offering tailored to the specific challenges of healthcare systems
Weaknesses
  • Deteriorated share price performance over medium- and long-term horizons
  • Lack of recent positive momentum drivers
Momentum

Current momentum is weak, marked by a downward trend that has persisted over several fiscal years. This environment calls for caution, suggesting that the company needs to strengthen product innovation or commercial penetration to reverse the trajectory before a more attractive repositioning for investors can be considered.

Similar stocks to CRANEWARE PLC ORD 1P

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone